Glycophospholipids and their Effect on Fatigue

Wednesday, 07 March 2012 by | Comments: 21
Reading Time: 12 minutes

Michael Ash interviewed colleague Dr Rita Ellithorpe MD for CAM on the clinical application of a patent pending form of phospholipids known as glycophospholipids and commercially sold as NT Factor and referred to as Lipid Replacement Therapy® (LRT®).

Unusually for many food supplements, glycophospholipids have been the primary ingredient in a number of research papers, some of which has had Dr Ellithorpe as a primary contributor. Her colleagues in this work have included Prof Garth Nicolson and Dr Settenari. References relating to some of these studies may be found at the end of the interview. LRT® is scientifically validated in 9 preclinical and clinical trials over the past 15 years, with millions of doses safely taken by consumers.  More than 25 articles in scientific and medical journals have been published on its benefits.